Cargando…
Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B(100)–Reactive CD4(+) T-Regulatory Cells
Throughout the inflammatory response that accompanies atherosclerosis, autoreactive CD4(+) T-helper cells accumulate in the atherosclerotic plaque. Apolipoprotein B(100) (apoB), the core protein of low-density lipoprotein, is an autoantigen that drives the generation of pathogenic T-helper type 1 (T...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515473/ https://www.ncbi.nlm.nih.gov/pubmed/32703007 http://dx.doi.org/10.1161/CIRCULATIONAHA.119.042863 |
_version_ | 1783586821506072576 |
---|---|
author | Wolf, Dennis Gerhardt, Teresa Winkels, Holger Michel, Nathaly Anto Pramod, Akula Bala Ghosheh, Yanal Brunel, Simon Buscher, Konrad Miller, Jacqueline McArdle, Sara Baas, Livia Kobiyama, Kouji Vassallo, Melanie Ehinger, Erik Dileepan, Thamotharampillai Ali, Amal Schell, Maximilian Mikulski, Zbigniew Sidler, Daniel Kimura, Takayuki Sheng, Xia Horstmann, Hauke Hansen, Sophie Mitre, Lucia Sol Stachon, Peter Hilgendorf, Ingo Gaddis, Dalia E. Hedrick, Catherine Benedict, Chris A. Peters, Bjoern Zirlik, Andreas Sette, Alessandro Ley, Klaus |
author_facet | Wolf, Dennis Gerhardt, Teresa Winkels, Holger Michel, Nathaly Anto Pramod, Akula Bala Ghosheh, Yanal Brunel, Simon Buscher, Konrad Miller, Jacqueline McArdle, Sara Baas, Livia Kobiyama, Kouji Vassallo, Melanie Ehinger, Erik Dileepan, Thamotharampillai Ali, Amal Schell, Maximilian Mikulski, Zbigniew Sidler, Daniel Kimura, Takayuki Sheng, Xia Horstmann, Hauke Hansen, Sophie Mitre, Lucia Sol Stachon, Peter Hilgendorf, Ingo Gaddis, Dalia E. Hedrick, Catherine Benedict, Chris A. Peters, Bjoern Zirlik, Andreas Sette, Alessandro Ley, Klaus |
author_sort | Wolf, Dennis |
collection | PubMed |
description | Throughout the inflammatory response that accompanies atherosclerosis, autoreactive CD4(+) T-helper cells accumulate in the atherosclerotic plaque. Apolipoprotein B(100) (apoB), the core protein of low-density lipoprotein, is an autoantigen that drives the generation of pathogenic T-helper type 1 (T(H)1) cells with proinflammatory cytokine secretion. Clinical data suggest the existence of apoB-specific CD4(+) T cells with an atheroprotective, regulatory T cell (T(reg)) phenotype in healthy individuals. Yet, the function of apoB-reactive T(regs) and their relationship with pathogenic T(H)1 cells remain unknown. METHODS: To interrogate the function of autoreactive CD4(+) T cells in atherosclerosis, we used a novel tetramer of major histocompatibility complex II to track T cells reactive to the mouse self-peptide apo B(978-993) (apoB(+)) at the single-cell level. RESULTS: We found that apoB(+) T cells build an oligoclonal population in lymph nodes of healthy mice that exhibit a T(reg)-like transcriptome, although only 21% of all apoB(+) T cells expressed the T(reg) transcription factor FoxP3 (Forkhead Box P3) protein as detected by flow cytometry. In single-cell RNA sequencing, apoB(+) T cells formed several clusters with mixed T(H) signatures that suggested overlapping multilineage phenotypes with pro- and anti-inflammatory transcripts of T(H)1, T helper cell type 2 (T(H)2), and T helper cell type 17 (T(H)17), and of follicular-helper T cells. ApoB(+) T cells were increased in mice and humans with atherosclerosis and progressively converted into pathogenic T(H)1/T(H)17-like cells with proinflammatory properties and only a residual T(reg) transcriptome. Plaque T cells that expanded during progression of atherosclerosis consistently showed a mixed T(H)1/T(H)17 phenotype in single-cell RNA sequencing. In addition, we observed a loss of FoxP3 in a fraction of apoB(+) T(regs) in lineage tracing of hyperlipidemic Apoe(–/–) mice. In adoptive transfer experiments, converting apoB(+) T(regs) failed to protect from atherosclerosis. CONCLUSIONS: Our results demonstrate an unexpected mixed phenotype of apoB-reactive autoimmune T cells in atherosclerosis and suggest an initially protective autoimmune response against apoB with a progressive derangement in clinical disease. These findings identify apoB autoreactive T(regs) as a novel cellular target in atherosclerosis. |
format | Online Article Text |
id | pubmed-7515473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-75154732020-10-14 Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B(100)–Reactive CD4(+) T-Regulatory Cells Wolf, Dennis Gerhardt, Teresa Winkels, Holger Michel, Nathaly Anto Pramod, Akula Bala Ghosheh, Yanal Brunel, Simon Buscher, Konrad Miller, Jacqueline McArdle, Sara Baas, Livia Kobiyama, Kouji Vassallo, Melanie Ehinger, Erik Dileepan, Thamotharampillai Ali, Amal Schell, Maximilian Mikulski, Zbigniew Sidler, Daniel Kimura, Takayuki Sheng, Xia Horstmann, Hauke Hansen, Sophie Mitre, Lucia Sol Stachon, Peter Hilgendorf, Ingo Gaddis, Dalia E. Hedrick, Catherine Benedict, Chris A. Peters, Bjoern Zirlik, Andreas Sette, Alessandro Ley, Klaus Circulation Original Research Articles Throughout the inflammatory response that accompanies atherosclerosis, autoreactive CD4(+) T-helper cells accumulate in the atherosclerotic plaque. Apolipoprotein B(100) (apoB), the core protein of low-density lipoprotein, is an autoantigen that drives the generation of pathogenic T-helper type 1 (T(H)1) cells with proinflammatory cytokine secretion. Clinical data suggest the existence of apoB-specific CD4(+) T cells with an atheroprotective, regulatory T cell (T(reg)) phenotype in healthy individuals. Yet, the function of apoB-reactive T(regs) and their relationship with pathogenic T(H)1 cells remain unknown. METHODS: To interrogate the function of autoreactive CD4(+) T cells in atherosclerosis, we used a novel tetramer of major histocompatibility complex II to track T cells reactive to the mouse self-peptide apo B(978-993) (apoB(+)) at the single-cell level. RESULTS: We found that apoB(+) T cells build an oligoclonal population in lymph nodes of healthy mice that exhibit a T(reg)-like transcriptome, although only 21% of all apoB(+) T cells expressed the T(reg) transcription factor FoxP3 (Forkhead Box P3) protein as detected by flow cytometry. In single-cell RNA sequencing, apoB(+) T cells formed several clusters with mixed T(H) signatures that suggested overlapping multilineage phenotypes with pro- and anti-inflammatory transcripts of T(H)1, T helper cell type 2 (T(H)2), and T helper cell type 17 (T(H)17), and of follicular-helper T cells. ApoB(+) T cells were increased in mice and humans with atherosclerosis and progressively converted into pathogenic T(H)1/T(H)17-like cells with proinflammatory properties and only a residual T(reg) transcriptome. Plaque T cells that expanded during progression of atherosclerosis consistently showed a mixed T(H)1/T(H)17 phenotype in single-cell RNA sequencing. In addition, we observed a loss of FoxP3 in a fraction of apoB(+) T(regs) in lineage tracing of hyperlipidemic Apoe(–/–) mice. In adoptive transfer experiments, converting apoB(+) T(regs) failed to protect from atherosclerosis. CONCLUSIONS: Our results demonstrate an unexpected mixed phenotype of apoB-reactive autoimmune T cells in atherosclerosis and suggest an initially protective autoimmune response against apoB with a progressive derangement in clinical disease. These findings identify apoB autoreactive T(regs) as a novel cellular target in atherosclerosis. Lippincott Williams & Wilkins 2020-07-24 2020-09-29 /pmc/articles/PMC7515473/ /pubmed/32703007 http://dx.doi.org/10.1161/CIRCULATIONAHA.119.042863 Text en © 2020 The Authors. Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. |
spellingShingle | Original Research Articles Wolf, Dennis Gerhardt, Teresa Winkels, Holger Michel, Nathaly Anto Pramod, Akula Bala Ghosheh, Yanal Brunel, Simon Buscher, Konrad Miller, Jacqueline McArdle, Sara Baas, Livia Kobiyama, Kouji Vassallo, Melanie Ehinger, Erik Dileepan, Thamotharampillai Ali, Amal Schell, Maximilian Mikulski, Zbigniew Sidler, Daniel Kimura, Takayuki Sheng, Xia Horstmann, Hauke Hansen, Sophie Mitre, Lucia Sol Stachon, Peter Hilgendorf, Ingo Gaddis, Dalia E. Hedrick, Catherine Benedict, Chris A. Peters, Bjoern Zirlik, Andreas Sette, Alessandro Ley, Klaus Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B(100)–Reactive CD4(+) T-Regulatory Cells |
title | Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B(100)–Reactive CD4(+) T-Regulatory Cells |
title_full | Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B(100)–Reactive CD4(+) T-Regulatory Cells |
title_fullStr | Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B(100)–Reactive CD4(+) T-Regulatory Cells |
title_full_unstemmed | Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B(100)–Reactive CD4(+) T-Regulatory Cells |
title_short | Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B(100)–Reactive CD4(+) T-Regulatory Cells |
title_sort | pathogenic autoimmunity in atherosclerosis evolves from initially protective apolipoprotein b(100)–reactive cd4(+) t-regulatory cells |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515473/ https://www.ncbi.nlm.nih.gov/pubmed/32703007 http://dx.doi.org/10.1161/CIRCULATIONAHA.119.042863 |
work_keys_str_mv | AT wolfdennis pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT gerhardtteresa pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT winkelsholger pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT michelnathalyanto pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT pramodakulabala pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT ghoshehyanal pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT brunelsimon pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT buscherkonrad pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT millerjacqueline pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT mcardlesara pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT baaslivia pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT kobiyamakouji pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT vassallomelanie pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT ehingererik pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT dileepanthamotharampillai pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT aliamal pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT schellmaximilian pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT mikulskizbigniew pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT sidlerdaniel pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT kimuratakayuki pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT shengxia pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT horstmannhauke pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT hansensophie pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT mitreluciasol pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT stachonpeter pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT hilgendorfingo pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT gaddisdaliae pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT hedrickcatherine pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT benedictchrisa pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT petersbjoern pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT zirlikandreas pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT settealessandro pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells AT leyklaus pathogenicautoimmunityinatherosclerosisevolvesfrominitiallyprotectiveapolipoproteinb100reactivecd4tregulatorycells |